Overcoming Cancer Drug Resistance Utilizing PROTAC Technology is a research paper published in Frontiers in Cell and Developmental Biology (2022). On theSindex it has a DataRank of 0. It has been cited 120 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA241191
National Institutes of Health
Grant: 5T32GM136583-05
Chemistry-Biology Interface Training Program at the University of Florida
National Institutes of Health
Grant: 5R01CA260239-05
Proteolysis-targeting chimera against BCL-XL inhibits breast cancer metastasis
National Institutes of Health
Grant: 5R01CA241191-03
Inhibition of Bcl-xL by Targeted Degradation
European Commission
Grant: 242003
NEURAL TRANSPLANTATION IN THE TREATMENT OF PATIENTS WITH PARKINSON’S DISEASE
National Institutes of Health
Grant: 5R01CA242003-03
Use of BCL-xL Proteolysis targeting chimeras to treat pancreatic cancer
FWCI
7.52
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals